Articles amb requisits d'accés públic - Shankar ChintaMés informació
No estan disponibles en cap lloc: 2
Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha
A Siddiqui, A Rane, S Rajagopalan, SJ Chinta, JK Andersen
Neurobiology of disease 93, 115-120, 2016
Requisits: US National Institutes of Health
Parkinson’s disease and aging
JK Andersen, S Chinta
Advances in Geroscience, 229-255, 2016
Requisits: US National Institutes of Health
Disponibles en algun lloc: 29
Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo
SJ Chinta, JK Mallajosyula, A Rane, JK Andersen
Neuroscience letters 486 (3), 235-239, 2010
Requisits: US National Institutes of Health
Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson’s disease
SJ Chinta, G Woods, M Demaria, A Rane, Y Zou, A McQuade, ...
Cell reports 22 (4), 930-940, 2018
Requisits: US Department of Energy, US National Institutes of Health
Redox imbalance in Parkinson's disease
SJ Chinta, JK Andersen
Biochimica et Biophysica Acta (BBA)-General Subjects 1780 (11), 1362-1367, 2008
Requisits: US National Institutes of Health
Cellular senescence and the aging brain
SJ Chinta, G Woods, A Rane, M Demaria, J Campisi, JK Andersen
Experimental gerontology 68, 3-7, 2015
Requisits: US National Institutes of Health
Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?
SJ Chinta, CA Lieu, M DeMaria, RM Laberge, J Campisi, JK Andersen
Journal of internal medicine 273 (5), 429-436, 2013
Requisits: US National Institutes of Health
Taurine deficiency as a driver of aging
P Singh, K Gollapalli, S Mangiola, D Schranner, MA Yusuf, M Chamoli, ...
Science 380 (6649), eabn9257, 2023
Requisits: US National Institutes of Health, German Research Foundation, Academy of …
Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for …
A Siddiqui, SJ Chinta, JK Mallajosyula, S Rajagopolan, I Hanson, A Rane, ...
Free Radical Biology and Medicine 53 (4), 993-1003, 2012
Requisits: US National Institutes of Health
Mitochondrial quality control via the PGC1α-TFEB signaling pathway is compromised by parkin Q311X mutation but independently restored by rapamycin
A Siddiqui, D Bhaumik, SJ Chinta, A Rane, S Rajagopalan, CA Lieu, ...
Journal of Neuroscience 35 (37), 12833-12844, 2015
Requisits: US National Institutes of Health
A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in …
DW Lee, D Kaur, SJ Chinta, S Rajagopalan, JK Andersen
Antioxidants & redox signaling 11 (9), 2083-2094, 2009
Requisits: US National Institutes of Health
Anti-inflammatory role of the isoflavone diadzein in lipopolysaccharide-stimulated microglia: implications for Parkinson’s disease
SJ Chinta, A Ganesan, P Reis-Rodrigues, GJ Lithgow, JK Andersen
Neurotoxicity research 23, 145-153, 2013
Requisits: US National Institutes of Health
Reactive oxygen species regulation by AIF-and complex I-depleted brain mitochondria
SJ Chinta, A Rane, N Yadava, JK Andersen, DG Nicholls, BM Polster
Free Radical Biology and Medicine 46 (7), 939-947, 2009
Requisits: US National Institutes of Health
Age-related behavioral phenotype of an astrocytic monoamine oxidase-B transgenic mouse model of Parkinson’s disease
CA Lieu, SJ Chinta, A Rane, JK Andersen
PloS one 8 (1), e54200, 2013
Requisits: US National Institutes of Health
Anti‐Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson’s Disease
D Leonoudakis, A Rane, S Angeli, GJ Lithgow, JK Andersen, SJ Chinta
Mediators of inflammation 2017 (1), 8302636, 2017
Requisits: US National Institutes of Health
Coupling endoplasmic reticulum stress to the cell death program in dopaminergic cells: effect of paraquat
SJ Chinta, A Rane, KS Poksay, DE Bredesen, JK Andersen, RV Rao
Neuromolecular medicine 10, 333-342, 2008
Requisits: US National Institutes of Health
Regulation of ATP13A2 via PHD2-HIF1α signaling is critical for cellular iron homeostasis: implications for Parkinson's disease
S Rajagopalan, A Rane, SJ Chinta, JK Andersen
Journal of Neuroscience 36 (4), 1086-1095, 2016
Requisits: US National Institutes of Health
Catecholamine metabolism drives generation of mitochondrial DNA deletions in dopaminergic neurons
JFG Neuhaus, OR Baris, S Hess, N Moser, H Schröder, SJ Chinta, ...
Brain 137 (2), 354-365, 2014
Requisits: German Research Foundation
Metabolic control analysis in a cellular model of elevated MAO-B: relevance to Parkinson’s disease
JK Mallajosyula, SJ Chinta, S Rajagopalan, DG Nicholls, JK Andersen
Neurotoxicity research 16, 186-193, 2009
Requisits: US National Institutes of Health
Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function
N Anand, A Holcom, M Broussalian, M Schmidt, SJ Chinta, GJ Lithgow, ...
Neurobiology of disease 139, 104786, 2020
Requisits: US National Institutes of Health
Les dades de publicació i de finançament es determinen automàticament per mitjà d'un programa informàtic